'Bayer
CropScience standalone net sales declined 8.00% to Rs 954.90 crore during
Q3FY24 compared to Q3FY23. Operating profit margin has jumped from 8.23% to
13.39%, leading to 49.77% rise in operating profit to Rs 127.90 crore. Raw material cost as a % of total sales (net
of stock adjustments) decreased from 46.40% to 45.05%. Purchase of finished goods cost fell from
5.48% to 2.14%. Employee cost decreased
from 16.03% to 14.10%. Other expenses
rose from 22.82% to 22.87%.
Other
income fell 3.95% to Rs 14.6 crore.
PBIDT rose 41.65% to Rs 142.5 crore.
Provision for interest fell 8.82% to Rs 3.1 crore.
PBDT rose
43.42% to Rs 139.4 crore.
Provision for
depreciation rose 6.29% to Rs 15.2 crore.&...
Pleaselogin & subscribe to view the full report.
More Reports
-
Sales up 10.26%, while PAT decreased by 2.44%.
-
-
OP up 46.05% and NP up 74.12%
-
(08-Nov-2024)
Sanofi India
|
|